概括
一种富含VII因子的前热血素复合物缩物有效地控制了肝脏疾病患者的凝血缺陷. 这种缩剂提供了一种有前途的治疗选择,用于暂时纠正凝血,而不会引起不良凝血事件.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝脏疾病经常导致凝血缺陷.
- 传统的前激素复合物缩剂已经显示出有限的疗效和风险,如散布的血管内凝血.
研究的目的:
- 评价一种富含第七因子的前热血素复合物缩剂,用于治疗肝病患者的凝血缺陷.
- 评估本缩剂在预防出血并发症和诱导血管内凝血方面的安全性和有效性.
主要方法:
- 患有肝病和凝血缺陷的13名患者接受了富含第七因子的前素复合物缩剂.
- 输液后立即和长达24小时的时间内监测凝血参数.
- 肝脏活检是在输液后立即进行的.
主要成果:
- 所有患者都观察到凝血的立即和充分纠正.
- 凝血水平在4小时内出现了一些恶化,在24小时后恢复到输液前的水平.
- 肝活检期间没有出现出血并发症,也没有发现诱导的血管内凝血的证据.
结论:
- 富含VII因子的前素复合缩物提供了有效的暂时纠正肝脏疾病中的凝血缺陷.
- 这种缩剂似乎是一个比其他前列红素复合物缩剂更安全的替代品,避免诱导的血管内凝血.
- 它可能是肝脏疾病患者的首选治疗方法,需要暂时改善凝血功能.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...


